PEAK6
BMY icon

PEAK6’s Bristol-Myers Squibb BMY Stock Holding History

PEAK6’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.06M Sell
66,900
-81,200
-55% -$4.73M 0.01% 1004
2025
Q4 		$7.99M Buy
148,100
+118,100
+394% +$5.68M 0.01% 741
2025
Q3 		$1.35M Sell
30,000
-60,000
-67% -$2.8M ﹤0.01% 1709
2025
Q2 		$4.17M Sell
90,000
-105,100
-54% -$5.16M 0.01% 1052
2025
Q1 		$11.9M Sell
195,100
-43,200
-18% -$2.52M 0.03% 514
2024
Q4 		$13.5M Buy
+238,300
New +$13.3M 0.03% 462

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6's BMY Position: Q1 2025 in Review

PEAK6 sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 15,126 shares — an estimated $882K sold.

PEAK6 first reported a position in BMY in Q4 2024 and held it in 1 quarter. The position peaked at $856K in Q4 2024. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • PEAK6 reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • PEAK6 sold 15,126 Bristol-Myers Squibb shares in Q1 2025, an estimated $882K.
  • PEAK6 first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 1 quarter.
  • PEAK6's Bristol-Myers Squibb position peaked at $856K in Q4 2024.
  • 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on PEAK6's 13F filing for Q1 2025, filed 14 May 2025.